Article Sidebar
Article Details
Copyright remains in the Author’s name. The work is licensed under a Creative Commons Attribution - Noncommercial Works License. Authors are required to complete and sign an Author Agreement form that outlines Author and Publisher rights and terms of publication. The Agreement form should be uploaded along with other submissions files and any submission will be considered incomplete without it [forthcoming].
Material submitted for publication in the SAMJ is accepted provided it has not been published or submitted for publication elsewhere. Please inform the editorial team if the main findings of your paper have been presented at a conference and published in abstract form, to avoid copyright infringement. The SAMJ does not hold itself responsible for statements made by the authors.
Previously published images
If an image/figure has been previously published, permission to reproduce or alter it must be obtained by the authors from the original publisher and the figure legend must give full credit to the original source. This credit should be accompanied by a letter indicating that permission to reproduce the image has been granted to the author/s. This letter should be uploaded as a supplementary file during submission.
Main Article Content
Oral midazolam in paediatric premedication
Abstract
In a premedication study involving 135 children, aged 1 - 10 years, four regimens were investigated: (I) no premedication; (il) oral trimeprazine tartrate 2 mg/kg, methadone 0,1 mg/kg, droperidol 0,15 mg/kg (TMD); (iil) intramuscular midazolam . (Dormicum; Roche) 0,15 mg/kg; and (iv) oral midazolam 0,45 mg/kg. All premedications were given 60 'minutes before a standard halothane anaesthetic. No impairment of cardiovascular stability occurred but after premedication the mean oxygen saturation decreased by 1,6% and 1,1%, respectively, in the intramuscular midazolam and TMDgroups. Overall, children under 5 years of age behaved less satisfactorily in the holding room and at induction, than those over 5 years (P < 0,01). Midazolam, intramuscularty and orally, produced more satisfactory behaviour than the other two regimens (P< 0,05) and, combined with a 70% more rapid recovery than the TMD regimen (P < 0,05), suggests that oral midazolam is a more effective paediatric premedication agent than placebo orTMD.
